Sempra

Market Movers (8-K)

NYSE
Sempra announces the appointment of Justin C. Bird as Executive Vice President and Chief Financial Officer, effective around the closing of its infrastructure equity sale.
NYSE
Sempra's California utilities, SDG&E and SoCalGas, have filed their 2028 General Rate Case applications with the CPUC, requesting approval for test year revenue requirements and subsequent attrition adjustments.
NYSE
Sempra has successfully closed a public offering of $1 billion in Floating Rate Notes due 2028, with net proceeds of approximately $998.5 million.
Capital raise
NYSE
Southern California Gas Company has successfully completed a $650 million offering of 5.900% First Mortgage Bonds maturing in 2056.
Capital raise
NYSE
Sempra's annual meeting saw shareholders re-elect all eleven director nominees, ratify Deloitte & Touche LLP as auditors, and approve executive compensation, while rejecting a proposal for an independent board chairman.
NYSE
Southern California Gas Company has issued $650 million in new first mortgage bonds to fund its operations.
Capital raise

Quarterly Earnings (10-Q)

NYSE
Sempra's third-quarter earnings were significantly impacted by one-time tax expenses related to the planned divestiture of Sempra Infrastructure Partners and Ecogas, despite strong operational performance from its California and Texas utilities.
Delay expected
Worse than expected
Capital raise
NYSE
Sempra reports a significant drop in Q2 2025 net income and EPS, primarily due to unfavorable foreign currency and inflation effects in Mexico and a tax expense from the planned sale of its Ecogas subsidiary, despite increased capital expenditures in key infrastructure projects.
Worse than expected
Delay expected
Capital raise
NYSE
Sempra Energy announces its financial results for the first quarter of 2025, highlighting key financial metrics and strategic developments across its operating segments.
Better than expected
Capital raise
NYSE
Sempra's third quarter 2024 earnings reflect a complex interplay of regulatory changes, operational adjustments, and market fluctuations across its diverse segments.
Worse than expected
Capital raise
NYSE
Sempra's Q2 2024 results show a complex picture with increased earnings in some segments offset by challenges in others, alongside significant regulatory and market influences.
Worse than expected
Capital raise
NYSE
Sempra's first quarter results show a decrease in earnings, influenced by lower natural gas prices and regulatory adjustments, alongside growth in its Texas utilities segment.
Worse than expected
Capital raise

Annual Reports (10-K)

NYSE
Sempra outlines its capital stock and debt securities in a recent SEC filing, highlighting key features and rights.
NYSE
Sempra's 2024 10-K filing highlights its energy infrastructure investments, regulatory environment, and financial performance across its California, Texas, and Infrastructure segments.
Worse than expected
Delay expected
Capital raise
NYSE
Sempra's recent SEC filing provides a detailed description of its registered capital stock, including common stock and debt securities, as well as preferred stock not registered under the Exchange Act.

Insider Trading (Form 4)

NYSE
Sempra director Jack T. Taylor acquired phantom shares as part of his compensation, with details of the transaction filed with the SEC.
NYSE
Michael N. Mears, a Director at Sempra, acquired phantom shares as part of his director compensation.
NYSE
Sempra director Richard J. Mark acquired phantom shares as part of his director compensation, with details of the transaction filed with the SEC.
NYSE
Sempra director Jennifer M. Kirk acquired phantom shares as part of her director compensation, with details of the transaction filed with the SEC.
NYSE
Sempra director Pablo Ferrero acquired phantom shares as part of his director compensation, with the transaction date noted as July 1, 2026.
NYSE
Sempra Executive Vice President Caroline Ann Winn sold 8,000 shares of common stock on June 17, 2026.

Proxy Statements (Def-14A)

NYSE
Sempra's 2026 proxy statement outlines strong 2025 performance, a sharpened focus on regulated utility investments, and key shareholder voting matters including director elections and executive compensation.
Delay expected
Capital raise
NYSE
Sempra amends its proxy statement to reflect Jennifer M. Kirk's upcoming role as CEO of Exubrion Therapeutics, a veterinary therapeutics company.
NYSE
Sempra has filed a definitive proxy statement with the Securities and Exchange Commission.
NYSE
Sempra's 2025 Annual Shareholders Meeting will be held virtually on May 13, 2025, with shareholders voting on director elections, auditor ratification, and executive compensation.
Better than expected
NYSE
Sempra's recent proxy statement emphasizes its strong financial performance, diverse board, and recommendations against shareholder proposals regarding severance and environmental reporting.
Better than expected
NYSE
Sempra has filed a definitive proxy statement with the Securities and Exchange Commission.

Schedule 13G - Passive Investments

NYSE
Vanguard Portfolio Management has reported a beneficial ownership of 5.72% in Sempra's common stock as of June 30, 2026.
NYSE
Capital International Investors reports a 3.0% stake in Sempra's common stock as of March 31, 2026.
NYSE
Vanguard Capital Management disclosed a beneficial ownership of 49,287,960 shares, representing 7.54% of Sempra's common stock as of March 31, 2026.
NYSE
The Vanguard Group has filed an amendment to its Schedule 13G, disclosing a beneficial ownership of 11.6% in Sempra's common stock.
NYSE
Capital International Investors reports a 7.8% beneficial ownership stake in Sempra, holding over 50 million shares.
NYSE
Wellington Management Group LLP and its affiliates have filed an amended Schedule 13G, disclosing a beneficial ownership of 7.47% in Sempra's common stock as of March 31, 2025.